[Federal Register: October 8, 1999 (Volume 64, Number 195)]
[Notices]               
[Page 54900-54901]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08oc99-121]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Clinical Chemistry and Clinical Toxicology Devices Panel of the 
Medical Devices Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Clinical Chemistry and Clinical Toxicology 
Devices Panel of the Medical Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on October 28, 1999, 8:30 
a.m. to 5 p.m.
    Location: Corporate Bldg., conference room 020B, 9200 Corporate 
Blvd., Rockville, MD.
    Contact Person: Veronica J. Calvin, Center for Devices and 
Radiological Health (HFZ-440), Food and Drug Administration, 2098 
Gaither Rd., Rockville, MD 20850, 301-594-1243, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12514. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The committee will discuss and make recommendations on a 
premarket notification for an over-the-

[[Page 54901]]

counter device that measures triglycerides from whole blood 
fingersticks.
    Procedure: On October 28, 1999, from 9 a.m. to 5 p.m., the meeting 
is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
October 15, 1999. Oral presentations from the public will be scheduled 
between approximately 9:45 a.m. and 10:15 a.m. and between 
approximately 1:45 p.m. and 2:15 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before October 15, 1999, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Closed Committee Deliberations: On October 28, 1999, from 8:30 a.m. 
to 9 a.m., the meeting will be closed to permit discussion and review 
of trade secret and/or confidential commercial information regarding 
pending and future FDA issues. This portion of the meeting will be 
closed to permit discussion of this information (5 U.S.C. 552b(c)(4)).
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: September 30, 1999.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 99-26219 Filed 10-7-99; 8:45 am]
BILLING CODE 4160-01-F